Sarah Mutinsky, JD, MPH

Mutinsky advises clients on program development, compliance, and regulatory and legislative advocacy in matters of health care law, policy, and financing.

She works with clients to develop tailored Medicaid funding programs and means of financing the nonfederal share of those programs — from supplemental funding for serving low-income patients, graduate medical education, and workforce support to Medicaid demonstration waiver programs and managed care innovations. Mutinsky regularly works with providers, local governments, state Medicaid agencies, and the federal Centers for Medicare & Medicaid Services to conceptualize and implement these programs. Through long-term strategic engagements, she helps clients adapt and evolve with new challenges and opportunities.

Mutinsky also advises clients participating in the 340B Drug Pricing Program, informed by years of insight into the ever-changing regulatory and political environment around this program and its intersection with changes across the health care system.

Mutinsky serves as Washington counsel to America’s Essential Hospitals, using lessons from on-the-ground work to inform federal policy development, and, in turn, leveraging insight from national regulatory and legislative advocacy to further the interests of individual providers and state and local efforts.

Mutinsky joined Eyman Associates upon its inception in November 2011, after several years as an associate in the Health Care Group at Ropes & Gray LLP and Powell Goldstein LLP (now Bryan Cave). Before practicing law, Mutinsky worked as a consultant specializing in health care market research and sales force analysis. She holds a juris doctorate and master’s degree in public health from The George Washington University and a bachelor’s degree from Princeton University.